Goldman Sachs Promotes Seven Partners to Management Committee
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jan 26 2026
0mins
Source: seekingalpha
- Management Expansion: Goldman Sachs has promoted seven partners to its management committee, increasing the decision-making body to 47 members, reflecting the company's strategic focus on its Asset & Wealth Management business.
- Clear Strategic Goals: CEO David Solomon stated that continuing to grow the Asset & Wealth Management business is a core strategic objective, and this new leadership team will help advance the development of a global business platform.
- Leadership Composition: The newly promoted partners include global heads of Private Credit and Wealth Management, showcasing Goldman Sachs' leadership in diversified investments and wealth management.
- Positive Stock Reaction: Goldman Sachs' stock rose 1.2% in Monday morning trading, indicating a positive market response to the company's strategic adjustments, which may enhance investor confidence.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy GS?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on GS
Wall Street analysts forecast GS stock price to fall
12 Analyst Rating
5 Buy
7 Hold
0 Sell
Moderate Buy
Current: 994.520
Low
604.00
Averages
951.45
High
1100
Current: 994.520
Low
604.00
Averages
951.45
High
1100
About GS
The Goldman Sachs Group, Inc. is a global financial institution that delivers a range of financial services to a large and diversified client base that includes corporations, financial institutions, governments and individuals. Its segments include Global Banking & Markets, Asset & Wealth Management and Platform Solutions. The Global Banking & Markets segment offers a range of services, including financing, advisory services, risk distribution, and hedging for its institutional and corporate clients. It facilitates client transactions and makes markets in fixed income, equity, currency and commodity products. The Asset & Wealth Management segment manages assets and offers investment products across all asset classes to a diverse set of clients. It also provides investing and wealth advisory solutions. The Platform Solutions segment includes consumer platforms, such as partnerships offering credit cards and point-of-sale financing, and transaction banking and other platform businesses.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
CD Rates Decline but Remain Competitive
- Current CD Rates: Short-term CDs currently offer annual rates typically between 4% and 4.5%, which, despite an overall decline, remain attractive compared to traditional savings accounts, indicating their ongoing relevance in the market.
- Historical Rate Trends: Since 2009, CD rates have experienced significant fluctuations, with one-year CDs averaging around 1% and five-year CDs below 2%, illustrating the impact of economic cycles on interest rates.
- Fed Policy Impact: The Federal Reserve raised rates 11 times between March 2022 and July 2023, which boosted CD rates; although recent declines have occurred, current rates still exceed historical averages, reflecting signs of economic recovery.
- Factors in Choosing CDs: When selecting a CD, it is crucial to consider not only the APY but also the term length, type of financial institution, and account terms to ensure alignment with personal financial goals and maximize returns.
See More
Goldman Sachs Sells Private Credit Shares at NAV
- Share Sale Overview: Goldman Sachs' private credit manager sold 3,372,858 Class I shares for approximately $83.19 million and 40,546 Class S shares for about $1 million, indicating active participation in the private market.
- Net Asset Value Performance: As of April 30, both Class I and S shares had a net asset value of $24.66 per share, reflecting Goldman Sachs' stability and investor confidence in its private credit offerings.
- Yield Analysis: Year-to-date returns as of April 30 were estimated at 1.7% for Class I shares and 1.0% for Class S shares, suggesting that Goldman Sachs' private credit products remain attractive in the current market environment.
- Market Environment Impact: Goldman Sachs' operations in the private credit market are intertwined with ongoing risks from Middle East conflicts and inflation, which may influence its future investment strategies and market performance.
See More
Market Performance Review Since Last CNBC Investing Club Meeting
- Overall Market Performance: Since the April 16 meeting, the S&P 500 has risen by 6.7% and the Nasdaq by 10.6%, indicating a strong market rebound and significantly boosting investor confidence in equities.
- Outstanding Performance by Arm: Arm's stock surged 97.9% since our position initiation, driven by robust demand expectations for CPUs, particularly in the AI sector, with projected revenues of $20 billion this year greatly enhancing its royalty business.
- Cybersecurity Stocks Rebound: CrowdStrike and Palo Alto Networks saw increases of 60.6% and 53.8%, respectively, and despite ZScaler's negative impact, the market remains optimistic about their growth prospects, with price targets raised by multiple Wall Street firms.
- Underperformance of Meta and Home Depot: Meta's stock fell 9.5% primarily due to investor concerns over its spending on generative AI, while Home Depot dropped 7.9% as high mortgage rates dampened growth expectations, reflecting a lack of confidence in their future performance.
See More
Analysis of Berkshire Hathaway's Q1 Performance Under Greg Abel
- Small Position Cleanup: In Q1, Abel eliminated 16 small positions, including Visa and Amazon, none of which accounted for more than 1% of Berkshire's total portfolio, aiming to enhance focus and efficiency in the investment strategy to improve long-term performance.
- Decisive Exit from Losers: Berkshire sold off underperforming stocks like Pool Corp. and Domino's Pizza in Q1, which may have locked in losses, but Abel believes that timely exits are necessary to prevent dragging down overall investment performance amid uncertainty.
- Investment in Special Situations: Abel initiated new stakes in Delta Air Lines and Macy's during Q1, both facing systemic challenges, indicating a strategic willingness to invest in potentially undervalued companies that could yield returns in the future despite current difficulties.
- Increased Cash Reserves: As of the end of March, Berkshire's cash reserves reached $397 billion, suggesting that Abel may be waiting for more attractive investment opportunities while potentially shifting towards wholly-owned cash-generating businesses to reduce reliance on volatile stocks.
See More
Greg Abel's Strategic Shift at Berkshire Hathaway
- Portfolio Adjustment: New CEO Greg Abel reduced investments in long-held positions like Visa and Mastercard in Q1, indicating a shift away from smaller stakes, which may enhance the overall quality and return potential of the portfolio.
- Increased Cash Reserves: As of the end of March, Berkshire Hathaway's cash reserves reached a record $397 billion, reflecting the company's strategy to wait for more attractive investment opportunities in an overvalued stock market.
- New Investment Direction: Abel initiated new stakes in Delta Air Lines and Macy's during Q1, signaling a willingness to take on higher risks for potential returns despite the systemic challenges these companies face, which may alter the company's investment style.
- Long-Term Strategic Thinking: Abel's decisions suggest that Berkshire may gradually reduce reliance on volatile stocks and shift towards more controllable cash-generating businesses, potentially providing shareholders with more stable returns.
See More
Hemab Therapeutics Poised for Growth Post-IPO Amid Rare Disorder Treatment Progress
- Strong IPO Performance: Hemab Therapeutics went public on May 4 at $18 per share, doubling on its first day to a high of $36.61, indicating strong market confidence in its potential to treat rare diseases.
- Optimistic Analyst Ratings: Goldman Sachs initiated coverage with a Buy rating and a $36 price target, implying a 39% upside from Friday's close, reflecting high expectations for its drug sutacimig targeting rare bleeding disorders.
- Significant Market Potential: Sutacimig aims to treat Glanzmann's thrombasthenia and Factor VII deficiency, with only about 1,000 patients in the U.S., but up to five times that number in Gulf Cooperation Council countries, showcasing substantial market capture potential.
- Positive Clinical Trial Results: Early-phase trials of sutacimig demonstrated annualized bleeding rate reductions across all dosing regimens, while Hemab is also developing HMB-002 for the more common Von Willebrand disease, further enhancing its market outlook.
See More
CD Rates Decline but Remain Competitive
- Current CD Rates: Short-term CDs currently offer annual rates typically between 4% and 4.5%, which, despite an overall decline, remain attractive compared to traditional savings accounts, indicating their ongoing relevance in the market.
- Historical Rate Trends: Since 2009, CD rates have experienced significant fluctuations, with one-year CDs averaging around 1% and five-year CDs below 2%, illustrating the impact of economic cycles on interest rates.
- Fed Policy Impact: The Federal Reserve raised rates 11 times between March 2022 and July 2023, which boosted CD rates; although recent declines have occurred, current rates still exceed historical averages, reflecting signs of economic recovery.
- Factors in Choosing CDs: When selecting a CD, it is crucial to consider not only the APY but also the term length, type of financial institution, and account terms to ensure alignment with personal financial goals and maximize returns.
See More
Goldman Sachs Sells Private Credit Shares at NAV
- Share Sale Overview: Goldman Sachs' private credit manager sold 3,372,858 Class I shares for approximately $83.19 million and 40,546 Class S shares for about $1 million, indicating active participation in the private market.
- Net Asset Value Performance: As of April 30, both Class I and S shares had a net asset value of $24.66 per share, reflecting Goldman Sachs' stability and investor confidence in its private credit offerings.
- Yield Analysis: Year-to-date returns as of April 30 were estimated at 1.7% for Class I shares and 1.0% for Class S shares, suggesting that Goldman Sachs' private credit products remain attractive in the current market environment.
- Market Environment Impact: Goldman Sachs' operations in the private credit market are intertwined with ongoing risks from Middle East conflicts and inflation, which may influence its future investment strategies and market performance.
See More
Market Performance Review Since Last CNBC Investing Club Meeting
- Overall Market Performance: Since the April 16 meeting, the S&P 500 has risen by 6.7% and the Nasdaq by 10.6%, indicating a strong market rebound and significantly boosting investor confidence in equities.
- Outstanding Performance by Arm: Arm's stock surged 97.9% since our position initiation, driven by robust demand expectations for CPUs, particularly in the AI sector, with projected revenues of $20 billion this year greatly enhancing its royalty business.
- Cybersecurity Stocks Rebound: CrowdStrike and Palo Alto Networks saw increases of 60.6% and 53.8%, respectively, and despite ZScaler's negative impact, the market remains optimistic about their growth prospects, with price targets raised by multiple Wall Street firms.
- Underperformance of Meta and Home Depot: Meta's stock fell 9.5% primarily due to investor concerns over its spending on generative AI, while Home Depot dropped 7.9% as high mortgage rates dampened growth expectations, reflecting a lack of confidence in their future performance.
See More
Analysis of Berkshire Hathaway's Q1 Performance Under Greg Abel
- Small Position Cleanup: In Q1, Abel eliminated 16 small positions, including Visa and Amazon, none of which accounted for more than 1% of Berkshire's total portfolio, aiming to enhance focus and efficiency in the investment strategy to improve long-term performance.
- Decisive Exit from Losers: Berkshire sold off underperforming stocks like Pool Corp. and Domino's Pizza in Q1, which may have locked in losses, but Abel believes that timely exits are necessary to prevent dragging down overall investment performance amid uncertainty.
- Investment in Special Situations: Abel initiated new stakes in Delta Air Lines and Macy's during Q1, both facing systemic challenges, indicating a strategic willingness to invest in potentially undervalued companies that could yield returns in the future despite current difficulties.
- Increased Cash Reserves: As of the end of March, Berkshire's cash reserves reached $397 billion, suggesting that Abel may be waiting for more attractive investment opportunities while potentially shifting towards wholly-owned cash-generating businesses to reduce reliance on volatile stocks.
See More
Greg Abel's Strategic Shift at Berkshire Hathaway
- Portfolio Adjustment: New CEO Greg Abel reduced investments in long-held positions like Visa and Mastercard in Q1, indicating a shift away from smaller stakes, which may enhance the overall quality and return potential of the portfolio.
- Increased Cash Reserves: As of the end of March, Berkshire Hathaway's cash reserves reached a record $397 billion, reflecting the company's strategy to wait for more attractive investment opportunities in an overvalued stock market.
- New Investment Direction: Abel initiated new stakes in Delta Air Lines and Macy's during Q1, signaling a willingness to take on higher risks for potential returns despite the systemic challenges these companies face, which may alter the company's investment style.
- Long-Term Strategic Thinking: Abel's decisions suggest that Berkshire may gradually reduce reliance on volatile stocks and shift towards more controllable cash-generating businesses, potentially providing shareholders with more stable returns.
See More
Hemab Therapeutics Poised for Growth Post-IPO Amid Rare Disorder Treatment Progress
- Strong IPO Performance: Hemab Therapeutics went public on May 4 at $18 per share, doubling on its first day to a high of $36.61, indicating strong market confidence in its potential to treat rare diseases.
- Optimistic Analyst Ratings: Goldman Sachs initiated coverage with a Buy rating and a $36 price target, implying a 39% upside from Friday's close, reflecting high expectations for its drug sutacimig targeting rare bleeding disorders.
- Significant Market Potential: Sutacimig aims to treat Glanzmann's thrombasthenia and Factor VII deficiency, with only about 1,000 patients in the U.S., but up to five times that number in Gulf Cooperation Council countries, showcasing substantial market capture potential.
- Positive Clinical Trial Results: Early-phase trials of sutacimig demonstrated annualized bleeding rate reductions across all dosing regimens, while Hemab is also developing HMB-002 for the more common Von Willebrand disease, further enhancing its market outlook.
See More
